Sanofi provided insight into the logistics hurdles faced by vaccine makers in China after a distribution and sales rule changed.

China's Shanghai Fosun Pharmaceuticals has reportedly won a bidding war for India's privately held injectable maker Gland Pharma in a rare cross-…

Exceptions on 15 ingredients from a banned plant run by China's Zhejiang Hisun Pharmaceuticals have raised questions on the ability of inspectors to…

China Resources has teamed up with Australian investment bank Macquarie to buy a majority of cancer and cardio medical care provider GenesisCare in a $1.3…

Osaka-based Takeda Pharmaceutical is reviewing prospects to sell a majority stake in Wako Pure Chemical.

Management has offered to buy Beijing-based radiotherapy and diagnostic firm Concord Medical Services in a $228 million bid.

Hanmi Pharmaceutical eyes branded drugs, fast-paced R&D and investment in China to get growth on track.

Nichi-Iko Pharmaceutical will buy Sagent Pharmaceuticals in a $736 million all-cash deal with management and boards from both side agreeing to terms aimed at…

A rush by Chinese companies to buy healthcare-related assets abroad is in full swing, although risks in running the operations need to be considered.

M&A